Acciones RegeneRx Biopharmaceuticals, Inc. Other OTC
Acciones
RGRX
US75886X1081
Farmacéuticos
Ventas 2021 | 76,76 mil 71,95 mil | Ventas 2022 | 76,76 mil 71,95 mil | Capitalización | 19,94 M 18,69 M |
---|---|---|---|---|---|
Resultado Neto 2021 | -1 M -937 mil | Resultado Neto 2022 | -1 M -937 mil | VE / Ventas 2021 | 298 x |
Posición de caja neta 2021 | 66,69 mil 62,51 mil | Deuda neta 2022 | 1,16 M 1,08 M | VE / Ventas 2022 | 275 x |
P/E ratio 2021 |
-13,9
x | P/E ratio 2022 |
-11,5
x | Empleados | - |
Rendimiento 2021 * |
-
| Rendimiento 2022 |
-
| Flotante | 55,86 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 86 | 13/05/82 | |
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/01/84 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
J. Finkelstein
CEO | Chief Executive Officer | 72 | 01/01/84 |
Founder | 86 | 13/05/82 | |
Joe McNay
BRD | Director/Board Member | 90 | 01/01/02 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-4,24 % | 86,85 mil M | |
+2,76 % | 40,16 mil M | |
-16,98 % | 31,28 mil M | |
+57,86 % | 25,27 mil M | |
-16,24 % | 15,33 mil M | |
-9,12 % | 11,96 mil M | |
-42,56 % | 11,61 mil M | |
-17,10 % | 11,69 mil M | |
+6,89 % | 8831,13 M |